A case of suicide by self-injection of adrenaline.

Détails

ID Serval
serval:BIB_94AC085DEA11
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
A case of suicide by self-injection of adrenaline.
Périodique
Forensic Science, Medicine, and Pathology
Auteur(s)
Palmiere C., Bévalot F., Malicier D., Grouzmann E., Fracasso T., Fanton L.
ISSN
1556-2891 (Electronic)
ISSN-L
1547-769X
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
11
Numéro
3
Pages
421-426
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Résumé
Adrenaline (epinephrine) auto-injectors provide life-saving pre-hospital treatment for individuals experiencing anaphylaxis in a community setting. Errors in handling adrenaline auto-injectors, particularly by children and healthcare professionals, have been reported. Reports of adrenaline overdoses are limited in the medical literature. In most of these cases, accidental adrenaline administration results from medical error. Exogenous administration of catecholamine is responsible for cardiovascular and metabolic responses, which may cause supraventricular tachycardia, ventricular dysrhythmias and myocardial ischemia. The authors present a unique autopsy case involving a 34 year-old woman who intentionally self-injected adrenaline using an adrenaline auto-injector as part of a suicide plan. Catecholamines and metanephrines were measured in peripheral and cardiac blood as well as urine and vitreous humor. Based on the results of all postmortem investigations, the cause of death was determined to be cardiac dysrhythmia and cardiac arrest following adrenaline self-injection.
Mots-clé
Adult, Arrhythmias, Cardiac/chemically induced, Catecholamines/analysis, Epinephrine/administration & dosage, Epinephrine/adverse effects, Female, Heart Arrest/chemically induced, Humans, Injections, Intramuscular, Suicide, Sympathomimetics/administration & dosage, Sympathomimetics/adverse effects, Vitreous Body/chemistry
Pubmed
Web of science
Création de la notice
05/08/2015 8:39
Dernière modification de la notice
20/08/2019 15:57
Données d'usage